Daniel Öhlund

8.1k total citations · 2 hit papers
35 papers, 2.0k citations indexed

About

Daniel Öhlund is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Daniel Öhlund has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Daniel Öhlund's work include Pancreatic and Hepatic Oncology Research (20 papers), Cancer Cells and Metastasis (12 papers) and Cancer Genomics and Diagnostics (7 papers). Daniel Öhlund is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Cancer Cells and Metastasis (12 papers) and Cancer Genomics and Diagnostics (7 papers). Daniel Öhlund collaborates with scholars based in Sweden, United States and Finland. Daniel Öhlund's co-authors include David A. Tuveson, Ela Elyada, Malin Sund, Oskar Franklin, Christina Lundin, Steffen Rickelt, Richard O. Hynes, Chenxi Tian, Albrecht Neeße and Thomas M. Gress and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Experimental Medicine.

In The Last Decade

Daniel Öhlund

33 papers receiving 2.0k citations

Hit Papers

Fibroblast heterogeneity ... 2014 2026 2018 2022 2014 2019 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel Öhlund 1.3k 802 572 431 248 35 2.0k
Abdel Hosein 1.0k 0.8× 1.5k 1.9× 963 1.7× 418 1.0× 230 0.9× 17 2.4k
Jae Hong Im 1.1k 0.8× 953 1.2× 484 0.8× 815 1.9× 166 0.7× 23 2.2k
Ayuko Hoshino 780 0.6× 996 1.2× 641 1.1× 400 0.9× 225 0.9× 23 1.8k
Carmine F. Palermo 1.3k 1.0× 629 0.8× 405 0.7× 417 1.0× 242 1.0× 17 1.7k
Irina Matei 1.3k 1.0× 1.4k 1.8× 946 1.7× 692 1.6× 349 1.4× 24 2.8k
Antonina V. Kurtova 1.0k 0.8× 1.2k 1.5× 414 0.7× 606 1.4× 176 0.7× 20 2.6k
Tyler Saunders 2.1k 1.6× 962 1.2× 804 1.4× 437 1.0× 176 0.7× 9 2.7k
Ajeeta B. Dash 1.8k 1.4× 1.6k 2.0× 808 1.4× 523 1.2× 174 0.7× 23 3.6k
Robert J. Norgard 1.1k 0.8× 1.1k 1.3× 670 1.2× 340 0.8× 209 0.8× 16 2.0k
Kieran T. Mellody 647 0.5× 652 0.8× 523 0.9× 231 0.5× 150 0.6× 20 1.7k

Countries citing papers authored by Daniel Öhlund

Since Specialization
Citations

This map shows the geographic impact of Daniel Öhlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Öhlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Öhlund more than expected).

Fields of papers citing papers by Daniel Öhlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Öhlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Öhlund. The network helps show where Daniel Öhlund may publish in the future.

Co-authorship network of co-authors of Daniel Öhlund

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Öhlund. A scholar is included among the top collaborators of Daniel Öhlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Öhlund. Daniel Öhlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Corbo, Vincenzo, et al.. (2025). Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology. Experimental & Molecular Medicine. 57(1). 50–58. 7 indexed citations
3.
Hasselgren, Kristina, Caroline Williamsson, Poya Ghorbani, et al.. (2025). Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. BMC Surgery. 25(1). 299–299.
4.
5.
Espona‐Fiedler, Margarita, et al.. (2024). Overcoming therapy resistance in pancreatic cancer: New insights and future directions. Biochemical Pharmacology. 229. 116492–116492. 18 indexed citations
6.
Johansson, Mattias, Christina Lundin, Hanna Nyström, et al.. (2024). Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank. Journal of Gastrointestinal Oncology. 15(2). 755–767. 3 indexed citations
8.
Steiner, Corinna, Matthias Löhr, Patrick Maisonneuve, et al.. (2024). High prevalence of pancreatic steatosis in pancreatic cancer patients: A meta-analysis and systematic review. Pancreatology. 25(1). 98–107. 2 indexed citations
9.
Wurmser, Maud, et al.. (2023). Dysregulation of core neurodevelopmental pathways—a common feature of cancers with perineural invasion. Frontiers in Genetics. 14. 1181775–1181775. 3 indexed citations
10.
Chand, Karam, et al.. (2023). The effect of side chain variations on quinazoline-pyrimidine G-quadruplex DNA ligands. European Journal of Medicinal Chemistry. 248. 115103–115103. 9 indexed citations
11.
Öhlund, Daniel, et al.. (2023). Key aspects for conception and construction of co-culture models of tumor-stroma interactions. Frontiers in Bioengineering and Biotechnology. 11. 1150764–1150764. 13 indexed citations
12.
Frängsmyr, Lars, Ioannis S. Pateras, Matthias J. Mickert, et al.. (2022). Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer. Cancer Immunology Research. 11(1). 72–92. 26 indexed citations
13.
Dongre, Mitesh, et al.. (2021). Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits. Frontiers in Cell and Developmental Biology. 9. 787485–787485. 39 indexed citations
14.
Tian, Chenxi, Daniel Öhlund, Steffen Rickelt, et al.. (2020). Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma. Cancer Research. 80(7). 1461–1474. 128 indexed citations
15.
Ponz‐Sarvisé, Mariano, Vincenzo Corbo, Hervé Tiriac, et al.. (2019). Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Clinical Cancer Research. 25(22). 6742–6755. 41 indexed citations
16.
Neeße, Albrecht, Christian Bauer, Daniel Öhlund, et al.. (2018). Stromal biology and therapy in pancreatic cancer: ready for clinical translation?. Gut. 68(1). 159–171. 250 indexed citations
17.
Franklin, Oskar, Pär Jonsson, Erik Lundberg, et al.. (2017). Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer. Annals of Surgery. 267(4). 775–781. 23 indexed citations
18.
Öhlund, Daniel, Oskar Franklin, Erik Lundberg, Christina Lundin, & Malin Sund. (2013). Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer. 13(1). 154–154. 111 indexed citations
19.
Öhlund, Daniel, Christina Lundin, B. Ardnor, et al.. (2009). Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. British Journal of Cancer. 101(1). 91–97. 94 indexed citations
20.
Öhlund, Daniel, B. Ardnor, Mikael Öman, Peter Naredi, & Malin Sund. (2008). Expression pattern and circulating levels of endostatin in patients with pancreas cancer. International Journal of Cancer. 122(12). 2805–2810. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026